CompletedNot Applicable

The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms

Colombia, Latvia, New Zealand69 participantsStarted 2008-12

Plain-language summary

The purpose of this clinical study is to evaluate the safety and device performance of the Nellix® EndoVascular Aneurysm Sealing System (Nellix System) for the treatment of infrarenal abdominal aortic aneurysms.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. aneurysm ≥ 4.5 cm in diameter, or
✓. aneurysm is twice the diameter of the normal infrarenal aorta, or
✓. aneurysm is growing at a rate of ≥ 10 % per year

What they're measuring

Safety- Number of Major Adverse Events

Timeframe: 30 day

Device Performance

Timeframe: 30 days

Trial details

NCT IDNCT02048514

SponsorEndologix

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2017-12

View on ClinicalTrials.gov More Abdominal Aortic Aneurysms trials